Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage

World Neurosurgery

Volumn 75, Issue 2, 2011, Pages 269-274

  Murphy Human, Theresa ^a   Welch, Emily ^a   Zipfel, Gregory ^b   Diringer, Michael N ^b   Dhar, Rajat ^b  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Levetiracetam; Phenytoin; Seizures; Subarachnoid hemorrhage

Indexed keywords

ETIRACETAM; PHENYTOIN;

ADULT; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; SEIZURE; SUBARACHNOID HEMORRHAGE;

EID: 79953853965     PISSN: 18788750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.wneu.2010.09.002     Document Type: Review

References (35)

1. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, DiringerMN,Duldner JE, Jr., Harbaugh RE, Patel AB, Rosenwasser RH: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40:994-1025, 2009.
2. Buczacki SJ, Kirkpatrick PJ, Seeley HM, Hutchinson PJ: Late epilepsy following open surgery for aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 75:1620-2, 2004. (Pubitemid 39430620)
3. Butzkueven H, Evans AH, Pitman A, Leopold C, Jolley DJ, Kaye AH, Kilpatrick CJ, Davis SM: Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology 55:1315-20, 2000.
4. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I: Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 55:236-42, 2000. (Pubitemid 30604624)
5. Chang BS, Lowenstein DH: Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 60:10-6, 2003. (Pubitemid 36070636)
6. Chumnanvej S, Dunn IF, Kim DH: Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage. Neurosurgery 60:99-102, 2007. (Pubitemid 46102931)
7. Claassen J, Mayer SA, Hirsch LJ: Continuous EEG monitoring in patients with subarachnoid hemorrhage. J Clin Neurophysiol 22:92-8, 2005. (Pubitemid 40490400)
8. Claassen J, Peery S, Kreiter KT, Hirsch LJ, Du EY, Connolly ES, Mayer SA: Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 60:208-14, 2003. (Pubitemid 36152010)
9. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980. (Pubitemid 10159923)
10. Hart RG, Byer JA, Slaughter JR, Hewett JE, Easton JD: Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysms. Neurosurgery 8:417-21, 1981. (Pubitemid 11104838)
11. Hasan D, Schonck RS, Avezaat CJ, Tanghe HL, van Gijn J, van der Lugt PJ: Epileptic seizures after subarachnoid hemorrhage. Ann Neurol 33:286-91, 1993. (Pubitemid 23081160)
12. Jones KE, Puccio AM, Harshman KJ, Falcione B, Benedict N, Jankowitz BT, Stippler M, Fischer M, Sauber-Schatz EK, Fabio A, Darby JM, Okonkwo DO: Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus 25:E3, 2008.
13. Knake S, Gruener J, Hattemer K, Klein KM, Bauer S, Oertel WH, Hamer HM, Rosenow F: Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry 79:588-9, 2008. (Pubitemid 351571881)
14. LaRoche SM, Helmers SL: The new antiepileptic drugs: clinical applications. JAMA 291:615-20, 2004. (Pubitemid 38500316)
15. LaRoche SM, Helmers SL: The new antiepileptic drugs: scientific review. JAMA 291:605-14, 2004. (Pubitemid 38500315)
16. Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermottMW: Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol 93:349-54, 2009.
17. Lin CL, Dumont AS, Lieu AS, Yen CP, Hwang SL, Kwan AL, Kassell NF, Howng SL: Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg 99:978-85, 2003. (Pubitemid 44717392)
18. Lin YJ, ChangWN,ChangHW,HoJT, Lee TC, Wang HC, Tsai NW, Tsai MH, Lu CH: Risk factors and outcome of seizures after spontaneous aneurysmal subarachnoid hemorrhage. Eur J Neurol 15:451-7, 2008.
19. Liu KC, Bhardwaj A: Use of prophylactic anticonvulsants in neurologic critical care: a critical appraisal. Neurocrit Care 7:175-84, 2007. (Pubitemid 350242671)
20. Milligan TA, Hurwitz S, Bromfield EB: Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology 71:665-9, 2008.
21. Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, Sandercock P: International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366:809-17, 2005. (Pubitemid 41557380)
22. Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, Connolly ES, Mayer SA, Fitzsimmons BF: Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 36:583-7, 2005. (Pubitemid 40352567)
23. Newton HB, Goldlust SA, Pearl D: Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78:99-102, 2006. (Pubitemid 43786667)
24. Pinto AN, Canhao P, Ferro JM: Seizures at the onset of subarachnoid haemorrhage. J Neurol 243:161-4, 1996. (Pubitemid 26026653)
25. Rhoney DH, Tipps LB, Murry KR, Basham MC, Michael DB, Coplin WM: Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology 55:258-65, 2000. (Pubitemid 30604627)
26. Rose FC, Sarner M: Epilepsy after ruptured intracranial aneurysm. Br Med J 1:18-21, 1965.
27. Rosengart AJ, Huo JD, Tolentino J, Novakovic RL, Frank JI, Goldenberg FD, Macdonald RL: Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg 107:253-60, 2007. (Pubitemid 47219366)
28. Ruegg S, Naegelin Y, Hardmeier M, Winkler DT, Marsch S, Fuhr P: Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav 12:477-80, 2008.
29. Szaflarski JP, Meckler JM, Szaflarski M, Shutter LA, Privitera MD, Yates SL: Levetiracetam use in critically ill patients. Neurocrit Care 7:140-7, 2007. (Pubitemid 350242663)
30. Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA: Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 12:165-72, 2010.
31. Teasdale GM, Drake CG, Hunt W, Kassell N, Sano K, Pertuiset B, De Villiers JC: A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 51:1457, 1988.
32. Thomson T, Dahl ML, Kimland E: Therapeutic monitoring of antiepileptic drugs for epilepsy. Cochrane Database Syst Rev 1:CD002216, 2007.
33. Vespa PM, Miller C, McArthur D, Eliseo M, Etchepare M, Hirt D, Glenn TC, Martin N, Hovda D: Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med 35:2830-6, 2007. (Pubitemid 350175782)
34. Wang H, Gao J, Lassiter TF, McDonagh DL, Sheng H, Warner DS, Lynch JR, Laskowitz DT: Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit Care 5:71-8, 2006. (Pubitemid 44379157)
35. Zubkov AY, Wijdicks EF: Antiepileptic drugs in aneurysmal subarachnoid hemorrhage. Rev Neurol Dis 5:178-81, 2008.